Under promise and over deliver is generally the better play. The revenue forecasts in the sophisticated investor valuation feel quite out of reach at present.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game